Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Atea Pharmaceuticals Unveils New Data Supporting Bemnifosbuvir And Ruzasvir Combination For Hepatitis C Treatment At AASLD's Liver Meeting 2024; Phase 2 Findings Highlight Potential Efficacy

Author: Benzinga Newsdesk | November 15, 2024 12:02pm

Posted In: AVIR

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist